Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo

Michael Smith

Icahn School of Medicine at Mount Sinai

Press/Media

Period	18 Dec 2017 → 19 Dec 2017

Media coverage

3

Media coverage

Title	Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo
Media name/outlet	Ecancer Medicalscience
Country/Territory	United Kingdom
Date	19/12/17
URL	ecancer.org/news/13034-mutational-signatures-may-id-pts-with-br-ca-most-likely-to-benefit-from-platinum-based-chemo.php
Persons	Michael Smith

Title	Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo
Media name/outlet	Medical Xpress
Country/Territory	United States
Date	19/12/17
URL	https://medicalxpress.com/news/2017-12-mutational-signatures-id-pts-br.html
Persons	Michael Smith

Title	Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo
Media name/outlet	EurekAlert!
Country/Territory	United States
Date	18/12/17
URL	https://www.eurekalert.org/pub_releases/2017-12/aafc-msm121817.php
Persons	Michael Smith